DK Insider Notice: Proposed Sale of 7,135 Shares via Citigroup

Rhea-AI Filing Summary

Delek US Holdings, Inc. (DK) filed a Form 144 notifying the proposed sale of 7,135 shares of common stock through Citigroup Global Markets Inc. The aggregate market value of the proposed sale is $208,659.51 and the filing lists 60,152,407 shares outstanding. The proposed approximate sale date is 09/02/2025. The filing discloses that the shares were acquired through option exercises or vesting as compensation on specific dates between 09/30/2022 and 03/31/2025, with individual lots totaling 304, 237, 969, 651, 1,966, 2,211, 416, 208, and 173 shares respectively (which sum to 7,135). No securities sold by the same person in the past three months are reported. Certain filer contact and issuer identification fields in the filing appear blank or not provided in the excerpt.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 7,135 shares; size is immaterial relative to total outstanding shares.

The Form 144 documents a planned sale through a broker of 7,135 common shares with an aggregate value of $208,659.51, representing roughly 0.012% of the reported 60,152,407 shares outstanding. All lots were acquired via option exercises or vesting as compensation across 2022–2025. There are no reported sales by this person in the prior three months. From a market-impact perspective, this disclosure reads as a routine insider liquidity event rather than a material change to company capital structure or operations.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 procedure; no governance red flags in the notice itself.

The filing fulfills Rule 144 notice requirements by identifying the broker, number of shares, acquisition method, and acquisition dates. The origin of the shares—option exercise/vesting compensation—is clearly stated, which is standard for executive or employee dispositions. The absence of reported sales in the prior three months and the detailed lot-level acquisition dates support transparency. The excerpt lacks some filer contact and issuer identification details, which should be present in a complete filing; the missing fields in this excerpt limit third-party verification.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Citigroup Global Markets Inc 388 Greenwich Street New York NY 10013	7135	208659.51	60152407	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/30/2022	Option Exercised/Vesting Compensation	Issuer			304	09/30/2022	Option Exercised/Vesting Compensation
Common Stock	12/30/2022	Option Exercised/Vesting Compensation	Issuer			237	12/30/2022	Option Exercised/Vesting Compensation
Common Stock	03/31/2025	Option Exercised/Vesting Compensation	Issuer			969	03/31/2025	Option Exercised/Vesting Compensation
Common Stock	06/10/2023	Option Exercised/Vesting Compensation	Issuer			651	06/10/2023	Option Exercised/Vesting Compensation
Common Stock	06/09/2024	Option Exercised/Vesting Compensation	Issuer			1966	06/09/2024	Option Exercised/Vesting Compensation
Common Stock	06/10/2024	Option Exercised/Vesting Compensation	Issuer			2211	06/10/2024	Option Exercised/Vesting Compensation
Common Stock	09/10/2024	Option Exercised/Vesting Compensation	Issuer			416	09/10/2024	Option Exercised/Vesting Compensation
Common Stock	12/10/2024	Option Exercised/Vesting Compensation	Issuer			208	12/10/2024	Option Exercised/Vesting Compensation
Common Stock	03/10/2025	Option Exercised/Vesting Compensation	Issuer			173	03/10/2025	Option Exercised/Vesting Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Delek US Holdings (DK) report in this Form 144?

The filing notifies the proposed sale of 7,135 common shares through Citigroup Global Markets Inc. with an aggregate market value of $208,659.51.

When is the approximate date of the proposed sale for DK shares?

The filing lists the approximate date of sale as 09/02/2025.

How were the 7,135 shares acquired according to the filing?

All shares were acquired via option exercise/vesting compensation on dates between 09/30/2022 and 03/31/2025.

How many shares outstanding does the Form 144 report for the issuer?

The filing reports 60,152,407 shares outstanding.

Does the filing report any sales by the same person in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.